Dr. Jihad Hassan Abialmouna, M.D. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 2800 Sweet Home Rd, Suite#6, West Amherst, NY 14228 Phone: 716-691-1300 Fax: 716-691-5044 |
News Archive
UNAIDS Executive Director Michel Sidibe on Sunday at the opening of the 6th International AIDS Society (IAS) Conference on HIV Pathogenesis, Treatment and Prevention in Rome "called ... for an increase in access to drugs that help treat or prevent the spread of the disease, saying it is 'morally wrong' to keep millions of people off lifesaving medication," the Associated Press/Boston Globe reports.
According to a study in the United States although women have always had a greater susceptibility for developing Multiple Sclerosis (MS) than men, the numbers have rocketed in the last six decades.
As Congress debates the costs of reforming our health-care system, it should consider one significant collateral cost of not acting: maintaining the world's highest rate of incarceration (Tracy Velazquez, 10/7).
FIT Biotech, a privately held biotechnology company developing novel, proprietary immunotherapies for HIV/AIDS and other viral diseases, announced results today from a Phase II clinical trial. The company's immunomodulator FIT-06 showed unprecedented long-term reductions in viral load (approximately 0.5 log) and statistically significant CD4 cell count increases in HIV-infected, previously untreated patients. The effect lasted longer than two years in the absence of any anti-retroviral therapy.
Ameritox, the nation's leader in pain medication monitoring, announced today the presentation of a peer-reviewed scientific poster titled "Patterns of Drug Use in the Older Chronic Pain Population" at the American Pain Society Annual Meeting.
› Verified 9 days ago